Search
Spotlight
The OncLive Insider app is live!
CME Opportunities
The OncLive Insider app is live!
CME Opportunities
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
The OncLive Insider app is live!
CME Opportunities
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Immuno-Oncology | Specialty
home
clinical
immunology-oncology
Content Type
Role of PRRT in the Management of NETs
March 1st 2018
Deciding on SSA Treatment in NETs
March 1st 2018
Overview of Somatostatin Analogs for NETs
March 1st 2018
Symptom Control in Functional NETs
March 1st 2018
Risk Stratification and Management of NETs
March 1st 2018
Surgical Considerations for Neuroendocrine Tumors
March 1st 2018
Advances in the Management of NETs
March 1st 2018
Future Outlook in Pancreatic Cancer
February 27th 2018
Promising New Therapies in Pancreatic Cancer
February 27th 2018
Pancreatic Cancer: Looking Beyond Second-Line Therapy
February 27th 2018
Immunotherapy in MSI-High Pancreatic Tumors
February 27th 2018
Second-Line Decision-Making in Pancreatic Cancer
February 27th 2018
Impact of Second-Line Approval of Liposomal Irinotecan
February 27th 2018
Pancreatic Cancer: Data With Liposomal Irinotecan/5-FU
February 27th 2018
Dosing Options With Nab-Paclitaxel/Gemcitabine
February 27th 2018
Sequencing Strategies in Pancreatic Cancer
February 27th 2018
Choosing Frontline Therapy in Metastatic Disease
February 27th 2018
Recent Advances in Pancreatic Cancer Research
February 27th 2018
Hepatocellular Carcinoma: Future Role of Immunotherapy
February 27th 2018
Optimizing Checkpoint Inhibitor Combinations in HCC
February 27th 2018
NEXT PAGE
<
1
...
77
78
79
80
81
82
83
84
85
...
201
>
PREVIOUS PAGE
x